Pierre Gholam MD

@livermd.bsky.social

8 years ago

@EASLedu Highlight 1 from #ilc2017 is #bezafibrate RCT data in #PBC non responders. If confirmed, great news for @PBCers worldwide

Pierre Gholam MD

@livermd.bsky.social

8 years ago

@EASLedu other question is whether there is benefit from starting #UDCA #bezafibrate combo as initial therapy. Studies lacking. #ILC2017